Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. Read more about Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.
Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. Read more about Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.
Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. Read more about Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States.
HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. Read more about HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis.
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. Read more about Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
Seroepidemiology of human bocaviruses 1-4. Read more about Seroepidemiology of human bocaviruses 1-4.
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. Read more about The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
Identification of human papillomavirus type 58 lineages and the distribution worldwide. Read more about Identification of human papillomavirus type 58 lineages and the distribution worldwide.
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. Read more about Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. Read more about A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.
